Bottom line
FTXH vs SWHFX: the short answer
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and SWHFX (Schwab Health Care Fund) are both etfs.
FTXH is cheaper at 0.6% vs 0.8% — a difference of $20 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +6.5% for FTXH.
Updated Nov 19, 2026
FTXH vs SWHFX side by side
| FTXH | SWHFX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | First Trust | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.6% | 0.8% |
| Annual cost per $10k | $60 | $80 |
| 10-yr cost on $10k (prospectus) | — | $990 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.0% | +15.9% |
| 5-yr return (annualized) | +6.5% | +6.5% |
| 10-yr return (annualized) | — | +8.1% |
| Best quarter | +18.3% | +15.3% |
| Worst quarter | −17.4% | −12.1% |
| Net assets (fund) | $36.2M | $642.3M |
| Number of holdings | 51 | 80 |
| Portfolio turnover | 35% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FTXH | SWHFX | Difference |
|---|---|---|---|
| 2025 | +24.0% | +15.9% | +8.1% |
| 2024 | +3.0% | +0.1% | +2.9% |
| 2023 | −1.4% | +0.7% | −2.1% |
| 2022 | +2.5% | −4.7% | +7.2% |
| 2021 | +6.1% | +23.3% | −17.2% |
| 2020 | +10.9% | +12.9% | −2.0% |
| 2019 | +22.4% | +17.6% | +4.7% |
| 2018 | −8.4% | +4.0% | −12.3% |
| 2017 | +18.8% | +20.2% | −1.4% |
Source: Fund prospectus bar charts
Holdings overlap
9 of FTXH's top 25 holdings also appear in SWHFX's top 25.
| Holding | FTXH | SWHFX |
|---|---|---|
| Eli Lilly & Company | 7.77% | 13.92% |
| Abbvie Inc | 7.39% | 5.81% |
| Merck & Company Inc | 7.07% | 4.98% |
| Johnson & Johnson | 6.96% | 6.94% |
| Bristol-myers Squibb Company | 6.29% | 2.44% |
| Vertex Pharmaceuticals Inc | 3.41% | 1.89% |
| Amgen Inc | 3.18% | 2.58% |
| Gilead Sciences Inc | 2.89% | 3.24% |
| Incyte Corp | 2.39% | 1.37% |
Source: SEC Form N-PORT
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between FTXH and SWHFX?
Which is cheaper, FTXH or SWHFX?
Should I own both FTXH and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.